Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer - Concepedia

Concepedia

Publication | Open Access

Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer

DOI Full Paper Access

231

Citations

41

References

2008

Year

Michail Ignatiadis, Galatea Kallergi, Maria Ntoulia, Maria Perraki, Stella Apostolaki, Maria Kafousi, Grigorios Chlouverakis, Efstathios N. Stathopoulos, Evi Lianidou, Vassilis Georgoulias,

Clinical Cancer Research

Abstract

The detection of peripheral blood CK19mRNA+ and MGB1mRNA+ cells before adjuvant chemotherapy predicts poor DFS in women with early breast cancer.

References

	Year	Citations

Page 1